Transcriptomics

Dataset Information

0

Transcriptomic analysis of autistic brain reveals convergent molecular pathology [high-throughput sequence data]


ABSTRACT: Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder. To identify potential A2BP1-dependent differential splicing events in ASD brain, we performed high-throughput RNA sequencing (RNA-Seq) on three autism samples with significant downregulation of A2BP1 (average fold change by quantitative RT-PCR = 5.9) and three control samples with average A2BP1 levels. The list of potential A2BP1-depending differential splicing events in ASD is given in the Supplementary file linked at the foot of this record.

REANALYSED by: E-GEOD-30573

ORGANISM(S): Homo sapiens  

SUBMITTER: Steve Horvath   Benjamin J Blencowe  Jonathan Mill  Irina Voineagu  Yuan Tian  Xinchen Wang  Patrick Johnston  Daniel H Geschwind  Jennifer K Lowe  Rita M Cantor 

PROVIDER: E-GEOD-30573 | ArrayExpress | 2011-07-12

SECONDARY ACCESSION(S): SRP007483GSE30573PRJNA143369

REPOSITORIES: GEO, ArrayExpress, ENA

altmetric image

Publications


Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis.  ...[more]

Similar Datasets

2016-08-15 | E-GEOD-84989 | ArrayExpress
2011-02-01 | E-GEOD-26463 | ArrayExpress
2016-04-07 | E-GEOD-30573 | ExpressionAtlas
2015-09-01 | E-GEOD-69656 | ArrayExpress
2011-05-01 | E-GEOD-28521 | ArrayExpress
2011-05-01 | GSE28521 | GEO
2014-05-28 | E-GEOD-58001 | ArrayExpress
2007-09-01 | E-GEOD-5886 | ArrayExpress
2007-08-31 | E-GEOD-5888 | ArrayExpress
2013-09-03 | E-GEOD-44976 | ArrayExpress